A Decade Defining Moment for Health


H/Advisors Public Affairs publish report on the Health Sector

Health has moved to the very top of the European Commission’s agenda and to the epicentre of policymaking over the last three years, as the COVID-19 pandemic laid bare the urgent imperative to build a resilient and strong European Health Union.

We have seen the strengthening of agencies (ECDC, EMA), the creation of a new authority (HERA), and a range of new actions and goals for digital transformation and global health security. However, with medicines accounting for roughly one-fifth of Europe’s health spend, the major channel through which the EU shapes health systems is invariably via pharmaceutical legislation. The Commission’s November 2020 Pharmaceutical Strategy is a response not only to internal market issues, but also to global competition pressure in the sector.


Download the Report

Contact the team

Mark Twigg, CEO
H/Advisors Cicero

Michael Hotra, US Managing Director
H/Advisors Abernathy

Helena Walsh, EU Managing Director
H/Advisors Cicero